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Global surveillance for a novel rhinovirus genotype in-
dicated its association with community outbreaks and pedi-
atric respiratory disease in Africa, Asia, Australia, Europe, 
and North America. Molecular dating indicates that these 
viruses have been circulating for at least 250 years.
Acute respiratory illness (ARI) is the most frequent in-fectious disease of humans. Ordinary upper respira-
tory tract infections are usually self-limited; nevertheless, 
they result in major economic impact through loss of pro-
ductivity and strain on healthcare systems. Lower respira-
tory tract infections (LRTIs) are among the leading causes 
of death in children <5 years of age worldwide, particularly 
in resource-poor regions (1). Streptococcus pneumoniae 
and Haemophilus infl uenzae are important bacterial causes 
of ARI, although their impact is expected to decline with 
increasing vaccine coverage. Collectively, however, virus-
es dominate as causative agents in ARI. Viruses frequently 
implicated in ARI include infl uenza virus, respiratory syn-
cytial virus, metapneumovirus, parainfl uenza virus, human 
enterovirus (HEV), and human rhinovirus (HRV).
HRVs are grouped taxonomically into Human rhinovi-
rus A (HRV-A) and Human rhinovirus B (HRV-B), 2 spe-
cies within the family Picornaviridae (International Com-
mittee on Taxonomy of Viruses database [ICTVdb]; http://
phene.cpmc.columbia.edu). These nonenveloped, positive-
sense, single-stranded RNA viruses have been classifi ed se-
rologically and on the basis of antiviral susceptibility pro-
fi le, nucleotide sequence relatedness, and receptor usage (2). 
Phylogenetic analyses of viral protein VP4/VP2 and VP1 
coding regions indicate the presence of 74 serotypes in ge-
netic group A and 25 serotypes in genetic group B (2).
Isolated in the 1950s from persons with upper respi-
ratory tract symptoms (2,3), HRVs have become known 
as the common cold virus because they are implicated in 
≈50% of upper respiratory tract infections (4). Large com-
munity surveys, including the Virus Watch studies of the 
1960–1970s (5), have shed light on some aspects of HRV 
biology and epidemiology. HRVs were also observed in 
LRTIs soon after their recognition (3), and data support-
ing a causative association have accumulated over the past 
decade (6,7). HRVs have also been implicated in exacerba-
tions of asthma and chronic bronchitis and are increasingly 
reported in LRTIs of infants, elderly persons, and immuno-
compromised patients (4).
The Study
The advent of broad-range molecular assays, includ-
ing multiplex PCR and microarray systems, promises new 
insights into the epidemiology and pathogenesis of respi-
ratory disease (8,9), given that a laboratory diagnosis is 
not routinely achieved for a substantial portion of respi-
ratory specimens from symptomatic patients. We recently 
described the application of a multiplex PCR method for 
microbial surveillance wherein primers are attached to tags 
of varying mass that serve as digital signatures for their ge-
netic targets. Tags are cleaved from primers and recorded 
by mass spectroscopy, enabling a sensitive, inexpensive, 
and highly multiplexed microbial detection. We used the 
multiplex MassTag PCR system (10) to investigate respi-
ratory samples that had tested negative during routine di-
agnostic assessment. This previous study yielded pathogen 
candidates in approximately one third of cases, and in 8 
cases identifi ed a novel genetic clade of picornaviruses di-
vergent from the previously characterized clades, including 
HRV-A and-B (8). To assess whether this novel clade cir-
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culates outside New York state, where it was discovered in 
cases of infl uenzalike illness (ILI), we investigated respira-
tory specimens from Africa, Asia, Australia, and Europe. 
In most studies (Africa, Asia), the collecting laboratories 
performed MassTag PCR, and inert mass-tagged amplifi ca-
tion products were sent for analysis by mass spectrometry 
(MS); in other instances (Europe, Australia), inactivated 
nasopharyngeal swabs or aspirates were sent to New York 
for MassTag PCR and MS analysis.
Samples in South Africa were collected through a 
program for comprehensive surveillance of causes of re-
spiratory illness in hospitalized children in the Pretoria 
area. MassTag PCR was applied to 58 specimens collected 
during the 2006 season from symptomatic children in their 
fi rst year of life with no diagnosis available from previous 
clinical laboratory evaluation. Analysis of amplifi cation 
products by MS yielded positive signal for HEV/HRV in 
14 (24%) samples. Independent amplifi cation and sequence 
analysis of VP4/2 coding sequence (8) in both laboratories 
showed sequences that matched the novel genotype in 4 
(29%) samples obtained from patients with LRTIs and re-
spiratory distress (Table 1, Figure). Samples collected in 
Côte d’Ivoire, West Africa, were from symptomatic per-
sons living in the vicinity of Taϊ National Park. This loca-
tion was the most remote of our study; residents have lim-
ited contact with other human populations. In this location, 
2 (10%) HRV-A were identifi ed in the 52 samples available 
for analysis (Table 1, Figure).
In Nepal, viruses of the novel genotype were identifi ed 
in specimens collected during ILI surveillance or outbreaks 
of respiratory disease. Samples from ILI surveillance activ-
ities were collected in Kathmandu and Bharatpur. Outbreak 
samples were collected in the summer months from camps 
of >100,000 refugees from Bhutan located in Jhapa, south-
east Nepal. Samples represented all age groups and were 
collected from December 2005 through July 2006. The 
novel genotype was identifi ed by independent molecular 
typing in both laboratories in 4 (5%) samples (Table 1, Fig-
ure). In India, samples from 50 children with ARI, submit-
ted for routine laboratory analysis during the 2007 season, 
were evaluated by MassTag PCR. Independent molecular 
typing in both laboratories indicated the novel genotype in 
3 (6%) samples (Table 1, Figure).
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Table 1. Molecular diagnosis of ARI from 7 countries by using MassTag PCR* and VP4/2 sequencing† 
Picornavirus positive
Country Season(s) Samples Total Novel clade HRV-A HRV-B HEV % Male Age range (mean/median)
South Africa 2006 58 14 4 6 3 1 71 0.4–30 mo (5.6/3)
Côte d’Ivoire 2006 52 2 0 2 0 0 100 22–28 y (25/25)
Nepal 2005–06 80 17 4 7 5 1 56 0.25–56 y (8.5/3)
India 2007 50 6 3 3 0 0 83 4–36 mo (17.8/18)
Australia 2006 2 2 1 1 0 0 100 4–6 mo (5/5)
Denmark 2007 70 7 5 1 0 1 57 1–8 mo (2.9/2)
Spain 2003–2006 14‡ 14 6 5 3 0 86 1–96 mo (23.2/15.5)
*See (10). 
†ARI, acute respiratory illness; HRV, human rhinovirus; HEV, human enterovirus. 
‡With previous HRV diagnosis. 
Figure. Phylogenetic analysis of VP4/2 coding region of viruses 
identifi ed in association with acute respiratory illness (ARI) in South 
Africa, Côte d’Ivoire, Nepal, India, Western Australia, Denmark, and 
Spain (sequences deposited in GenBank under accession nos. 
EU697825–83). Phylogeny of VP4/2 nucleotide sequence (401 nt) 
was reconstructed by neighbor-joining analysis applying a Jukes-
Cantor model; the scale bar indicates nucleotide substitutions per 
site. Included for reference are sequences belonging to the novel 
genotype identifi ed in New York State (NY-003, –028, –041, –042, 
–060, and –074 [8]), similar viruses reported recently (QPM [11]; 
NAT01 and NAT045 [12]; and 024, 025, 026 [13]), and selected 
human rhinovirus A (HRV-A) serotypes (GenBank accession 
numbers for reference sequences are indicated in parentheses); 
HRV-B serotypes; human enterovirus C (HEV-C) viruses human 
coxsackievirus A1 and A24 (CV-A1, and CV-A24, respectively); 
human poliovirus 2 (PV-2); HEV-B viruses human echovirus 5 (E-5), 
human coxsackievirus B3 (CV-B3), and swine vesicular disease 
virus (CV-B5); HEV-D viruses human enterovirus 68 and 70 (EV-68, 
EV-70); porcine enterovirus B virus porcine enterovirus 9 (PEV-9); 
and HEV-A viruses human coxsackievirus A16 (CV-A16) and human 
enterovirus 71 (EV-71). SA, South Africa; IC, Côte d’Ivoire; HC, 
Nepal; IN, India; AUS, Australia; DK, Denmark; SO, Spain.
Additional sample sets were obtained through main 
diagnostic laboratories in Western Australia, Denmark, 
and Spain, representing random respiratory specimens sub-
mitted for laboratory analysis. In 1 sample available from 
Western Australia, the novel genotype was identifi ed in a 
preterm infant with undiagnosed, wheezy LRTI. The novel 
genotype was also found in 5 (7%) of 70 samples from 
Denmark and in 6 (43%) of 14 samples with previously 
diagnosed HRV infection from Spain (Table 1, Figure).
The 5% overall frequency of the novel genotype across 
our study samples, representing 34% of all detected picor-
navirus infections, and its observed global distribution, led 
us to analyze the accumulating sequence data for insights 
into their history. Rates of evolutionary change and the 
Time to the Most Recent Common Ancestor (TMRCA) 
of the novel clade were estimated by using the Bayesian 
Markov Chain Monte Carlo approach (BEAST package 
[14]; ), applying a relaxed molecular clock with an uncorre-
lated lognormal distribution of rates, a GTR + I + Γ4 model 
of nucleotide substitution (determined by MODELTEST 
[15]), and exponential population growth. Statistical un-
certainty in each parameter estimate is expressed as 95% 
highest probability density (HPD) values. The estimated 
mean rate of evolutionary change was 6.6 × 10–4 substi-
tutions/site/y (95% HPD = 0.3–14.6 × 10–4 substitutions/
site/y; 38 dated samples collected over 32 mo (8,16) (S.R. 
Dominguez et al., unpub. data). Under this rate the mean 
TMRCA was estimated at 1,800 y, although with wide 
variance caused by the short sequence available (95% HPD 
= 279–5,201 y). Despite the inherent sampling error, this 
analysis suggests that this third clade of rhinovirus has been 
circulating for >250 years. The diversity observed within 
the novel clade and its genetic distance from other HRV/
HEV were comparable to those seen for HRV-A, -B, or the 
HEV species (Table 2).
Conclusions
A clade of picornaviruses recently discovered in New 
York State is globally distributed and is found in associa-
tion with community outbreaks of ARI and severe LRTIs 
of infants. These viruses contribute both to a substantial 
proportion of previously undiagnosed respiratory illness 
and to diagnosed, but nontyped cases of HRV infection. 
Similar viruses were recently characterized also in Queen-
sland, Australia (11); California, USA (12); Hong Kong 
Special Administrative Region, People’s Republic of China 
(13); and Germany (16). Our fi ndings indicate the need for 
further investigation into this third (HRV-C) group of rhi-
noviruses with emphasis on epidemiology, pathogenesis, 
and strategies to prevent and ameliorate disease caused by 
HRV infection.
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